Related references
Note: Only part of the references are listed.Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature
Sonia Cheng et al.
CLINICAL ENDOCRINOLOGY (2012)
No Evidence of a Detrimental Effect of Cabergoline Therapy on Cardiac Valves in Patients with Acromegaly
Luigi Maione et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Improvement of cardiac parameters in patients with acromegaly treated with medical therapies
Annamaria Colao
PITUITARY (2012)
Clinical implications of growth hormone-secreting tumor subtypes
Katja Kiseljak-Vassiliades et al.
ENDOCRINE (2012)
Arthropathy in long-term cured acromeagaly is characterised by osteophytes without joint space narrowing: a comparison with generalised osteoarthritis
M. J. E. Wassenaar et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Clinical laboratory indices in the treatment of acromegaly
David R. Clemmons
CLINICA CHIMICA ACTA (2011)
Resistance to Somatostatin Analogs in Acromegaly
Annamaria Colao et al.
ENDOCRINE REVIEWS (2011)
High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly
M. J. E. Wassenaar et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy
Gherardo Mazziotti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study
Annamaria Colao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Somatotroph Tumor Progression during Pegvisomant Therapy: A Clinical and Molecular Study
M. Marazuela et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Current management practices for acromegaly: an international survey
A. Giustina et al.
PITUITARY (2011)
Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications
Marie-Lise et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2011)
Influence of diabetes mellitus on vertebral fractures in men with acromegaly
Gherardo Mazziotti et al.
ENDOCRINE (2011)
Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study
Ming Shen et al.
ENDOCRINE JOURNAL (2010)
Mortality in Patients with Pituitary Disease
Mark Sherlock et al.
ENDOCRINE REVIEWS (2010)
Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline
M. Lafeber et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial
Zhi-gang Mao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines
D. Dworakowska et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Endocrine Aspects of Obstructive Sleep Apnea
Pierre Attal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Female Gonadal Function before and after Treatment of Acromegaly
Michael Grynberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Acromegaly and Pregnancy: A Retrospective Multicenter Study of 59 Pregnancies in 46 Women
Philippe Caron et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial
S. Petersenn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A Consensus on Criteria for Cure of Acromegaly
A. Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Cardiac effects of 3 months treatment of acromegaly evaluated by magnetic resonance imaging and B-type natriuretic peptides
Mikkel Andreassen et al.
PITUITARY (2010)
Arthropathy in Acromegaly
Z. Killinger et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2010)
Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study
Claudia Battista et al.
CLINICAL ENDOCRINOLOGY (2009)
Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy
F. M. Swords et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly
M. Sherlock et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Growth Hormone Deficiency Is Associated with Decreased Quality of Life in Patients with Prior Acromegaly
Tamara Wexler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
Gherardo Mazziotti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Guidelines for Acromegaly Management: An Update
S. Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Acromegaly pathogenesis and treatment
Shlomo Melmed
JOURNAL OF CLINICAL INVESTIGATION (2009)
Management of aggressive pituitary adenomas: current treatment strategies
Michael Buchfelder
PITUITARY (2009)
Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide
N. Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2008)
Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging
Flavia R. B. van Haute et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Impact of musculoskeletal disease on quality of life in long-standing acromegaly
Anne Miller et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease
Maria Vittoria Davi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance
Maria P. Matta et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
Bernard Levin et al.
GASTROENTEROLOGY (2008)
Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant
S. J. C. M. M. Neggers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
No greater incidence or worsening of cardiac valve regurgitation with somatostatin analog treatment of acromegaly
Annamaria Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Prevalence of Vertebral Fractures in Men with Acromegaly
Gherardo Mazziotti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: A prospective, randomized trial
Sven M. Carlsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas
Chrysanthia A. Leontiou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline
John W. Funder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Mortality in acromegaly: A meta analysis
O. M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults
A. Giustina et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis
Theodoros Rokkas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Does acromegaly enhance mortality?
John Ayuk et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2008)
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly
Laura De Marinis et al.
PITUITARY (2008)
Treatment of acromegaly with pegvisomant during pregnancy: Maternal and fetal effects
Susan Riddle Brian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
Raquel S. Jallad et al.
CLINICAL ENDOCRINOLOGY (2007)
A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors
Sylvia L. Asa et al.
CANCER RESEARCH (2007)
Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly:: mutations are found in a subset of young patients with macroadenomas
Laure Cazabat et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Impact of somatostatin analogs on the heart in acromegaly: A metaanalysis
Patrick Maison et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Effect of transsphenoidal surgery on sleep apnoea in acromegaly
Lisa Sze et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Treatment with growth hormone receptor antagonist in acromegaly: Effect on cardiac structure and performance
Rosario Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Medical progress: Acromegaly
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Acromegaly and coronary disease: An integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography
Salvatore Cannavo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Acromegaly presenting with diabetic ketoacidosis, associated with retinitis pigmentosa and octreotide-induced bradycardia -: A case report and a review of the literature
Cihangir Erem et al.
ENDOCRINE (2006)
Pregnancy in acromegaly: a one-center experience
Renato Cozzi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: A prospective study in 99 patients
Annamaria Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Pituitary adenoma predisposition caused by germline mutations in the AIP gene
Outi Vierimaa et al.
SCIENCE (2006)
Uncontrolled acromegaly is associated with progressive mitral valvular regurgitation
AA van der Klaauw et al.
GROWTH HORMONE & IGF RESEARCH (2006)
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly
A Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Resistance to somatostatin analogs in acromegaly: An evolving concept?
M Gola et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2006)
Consensus statement: medical management of acromegaly
S Melmed et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Increased prevalence of radiological spinal deformities in active acromegaly: A cross-sectional study in postmenopausal women
S Bonadonna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Hypertension in acromegaly and in the normal population: prevalence and determinants
G Vitale et al.
CLINICAL ENDOCRINOLOGY (2005)
Late potentials and ventricular arrhythmias in acromegaly
P Maffei et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
A nationwide survey of mortality in acromegaly
R Kauppinen-Mäkelin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Morbidity after long-term remission for acromegaly: Persisting joint-related complaints cause reduced quality of life
NR Biermasz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly
JS Bevan
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'
P Nomikos et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs
P Petrossians et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly
J Ayuk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
A Colao et al.
ENDOCRINE REVIEWS (2004)
Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly
BL Herrmann et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Long-term outcome of patients with acromegaly and congestive heart failure
H Bihan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Diagnosis and treatment of acromegaly complications
A Giustina et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2003)
Optimizing control of acromegaly: Integrating a growth hormone receptor antagonist into the treatment algorithm
DR Clemmons et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Transsphenoidal surgery for acromegaly in Wales: Results based on stringent criteria of remission
P De et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
High prevalence of cardiac valve disease in acromegaly: An observational, analytical, case-control study
A Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Preoperative lanreotide treatment for GH-secreting pituitary adenomas:: effect on tumour volume and predictive factors of significant tumour shrinkage
T Lucas et al.
CLINICAL ENDOCRINOLOGY (2003)
Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly
A Colao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly
C Beauregard et al.
CLINICAL ENDOCRINOLOGY (2003)
Screening guidelines for colorectal cancer and polyps in patients with acromegaly
PJ Jenkins et al.
GUT (2002)
Guidelines for acromegaly management
S Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Somatostatin analogs in acromegaly
PU Freda
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas
ML Jaffrain-Rea et al.
ENDOCRINE-RELATED CANCER (2002)
Failure of radiotherapy in acromegaly
R Cozzi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)
Effect of Sandostatin® LAR® on sleep apnoea in acromegaly:: correlation with computerized tomographic cephalometry and hormonal activity
MSM Ip et al.
CLINICAL ENDOCRINOLOGY (2001)
Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre
T Abe et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)
Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study
L Katznelson et al.
CLINICAL ENDOCRINOLOGY (2001)
Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients
JA Verhelst et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Criteria for cure of acromegaly: A consensus statement
A Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
